Serotonin uptake and serotonin uptake inhibition (Q38004484)

26 August 2017

1 reference

title

Serotonin uptake and serotonin uptake inhibition (English)

1 reference

26 August 2017

0 references

Fuller RW

1

1 reference

26 August 2017

Wong DT

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

Annals of the New York Academy of Sciences

26 August 2017

published in

1 reference

26 August 2017

volume

600

1 reference

26 August 2017

page(s)

68-78; discussion 79-80

1 reference

Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Potent depletion of 5HT from monkey whole bloob by a new 5HT uptake inhibitor, paroxetine (FG 7051)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

dl-N-methyl-3-(o-methoxyphenoxy)-3-phenylpropylamine hydrochloride, Lilly 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Comparison of the specificity of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and chlorimipramine as amine uptake inhibitors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Effect of thymoleptics on fenfluramine-induced depletion of brain serotonin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Fluoxetine, a selective serotonin uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Autoradiographic localization of [3H]-imipramine binding sites: association with serotonergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Serotonin-dopamine interactions in the nigrostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

The effects of fluoxetine and zimeldine on the behavior of olfactory bulbectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Discriminative stimulus properties of L-5-hydroxytryptophan: behavioral evidence for multiple serotonin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Reduction of feeding behavior by the serotonin uptake inhibitor sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Fluoxetine enhances memory processing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

On the role of 5-hydroxytryptamine in drug-induced antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Antidepressants and weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Dopaminergic and serotoninergic anorectics differentially antagonize insulin- and 2-DG-induced hyperphagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Effect of zimelidine, a new antidepressant, on appetite and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Placebo controlled double-blind trial of fluvoxamine maleate in the obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

An investigation of the mechanisms of action of 5-hydroxytryptamine in the suppression of ethanol intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Monoamine uptake inhibitors attenuate ethanol intake in alcohol-preferring (P) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

Effects of imipramine, chlorimipramine, and fluoxetine on cataplexy in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

5-Hydroxytryptamine and antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16873.X

10.1111/J.1749-6632.1990.TB16873.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference